Hematology/Oncology, University of Washington, Seattle, WA
Dr. Risa Wong is a Hematology and Oncology fellow at the University of Washington and Fred Hutchinson Cancer Research Center. The American Board of Internal Medicine has certified her in internal medicine (physician and surgeon). She completed her first degree at the University of Washington and got a medical degree of Yale University School of Medicine.
Linkedin profileHead of the Neuroimmunology Center, S. Gerardo Hospital, Monza, Italy
Professor Guido Cavaletti is a professor of human anatomy at the School of Medicine and Surgery, vice-rector for research and Head of Experimental Neurology unit at the University of Milano-Bicocca. He also works as senior consultant neurologist and head of the outpatient clinic at the Department of Neurology, S. Gerardo University Hospital. He is currently the Chair of the Toxic Neuropathy Consortium of the Peripheral Nerve Society
Linkedin profile
Onco-Dermatology, Memorial Sloan Kettering Cancer Center, New York, NY
Dr. Mario Lacouture is a board-certified dermatologist at Mermorial Sloan Kettering Cancer Center in New York and director of a clinical program in Oncodermatology, first program in the field founded by himself in 2006. He specializes in advancing cancer care and its effect in dermatologic conditions of patients after cancer treatments, such as chemotherapy, radiotherapy, and immunotherapies.
Linkedin profile
Radiology Oncology, Jefferson University Physician, Philadelphia, PA
Dr. Dicker is a professor of the Radiation Oncology, Pharmacology, and experimental therapies at Thomas Jefferson University. He serves as co-chair Translational Science Committee for the NCI cooperative group. His research includes the use of “smart needles” for diagnostic and therapeutic applications and he also works in prostate cancer focuses on the “self-seeding” of prostate cells with metastatic properties back to the site of origin, which contributes to disease progression.
Profile LinkedIn
Linkedin profileAssociate Professor, Division of Gynecologic Oncology, Miami, Fl
Dr. Marilyn HUANG is a experienced research director of Translational Gynecologic Oncology and, researcher at Sylvester Comprehensive Cancer Center and associate professor of The University of Miami. Her research is centered on novel therapeutics and innovative drug combinations for trial programs. She has won multiple industry sponsors to evaluate new treatments in gynecologic malignancies, focused in immunotherapy.
Linkedin profileCardio-Oncology Expertise, Liverpool Heart & Chest Hospital, Liverpool, UK
Professor Lip, MD is a clinical researcher, Price-Evans chair of Cardiovascular Medicine and director of the Liverpool Centre for Cardiovascular Science, at the University of Liverpool, UK. At Aalborg University in Denmark, he is a well-known Professor and adjunct professor at Yonsei University in Korea.
Professor of Psycho Oncology, University of Sussex Brighton, UK
Professor Dame Lesley Fallowfield is professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex where she is director of Sussex Health Outcomes research & education in cancer. Her research interests include assessment of patient reported outcomes (PROs), supportive interventions for symptoms and side-effects of cancer and its treatments. In her career path she has published over 400 papers, book chapters and 3 textbooks. She also lectures and runs training workshops around the world in psychosocial oncology, quality of life assessment and communication skills.
In 2010, she was awarded the Pfizer/BOA Excellence in Oncology Lifetime Achievement Award and in 2016 she was made a Dame Commander of the order of the British Empire after her debut as fellow of the UK Academy of medical Sciences.
Linkedin profileLeading Senior Physician Haematology and Oncology, University of Heidelberg, Germany
Professor Karin Jordan is the leading senior physician of the Department of Hematology and Oncology at the University Hospital in Heidelberg, Germany. She also actively works as Chief Physician in the Ernst von Bergmann Clinic in Potsdam. Germany.
Professor Jordan has served as a board member of MASCC/ESMO Antiemetic Guideline Consensus Panel in 2009 and 2015 as well as a member of the ASCO antiemetic guideline panel. She is the ESMO Faculty coordinator for Supportive & Palliative Care and the ESMO Clinical Practice Guidelines subject editor for the supportive care section. Professor Jordan has authored and co-authored more than 120 publications. Her major area of interest is supportive care with a special focus on antiemetic treatment of chemotherapy-induced nausea and vomiting and side effects of new drugs.
Linkedin profileChief of Medical Oncology, and Scientific Coordinator, Hospital Clínic Barcelona, Spain
Professor Gascón holds the position of co-director of the Molecular and Translational Oncology Laboratory of the Faculty of Biology, University of Barcelona.
He is board-certified in internal medicine and hematology, as well as medical oncology. From 1985 to 1999, he was the Director of the Division of Hematology-Oncology at UMDNJ-New Jersey Medical School where he graduated with a PhD. During 20 years he worked as Director, Division of Medical Oncology and, Scientific Coordinator of the Hematology-Oncology Department, at the Hospital Clinic in Barcelona.
He has published more than 200 papers in peer-reviewed journals. His main clinical interests are in breast and colorectal cancer and in palliative care, in particular bone marrow toxicities.
Linkedin ProfileAssociate Professor GI Medical Oncology, MD Anderson Cancer Center Houston, TX
Professor Dame Lesley Fallowfield is professor of Psycho-oncology at Brighton & Sussex Medical School, University of Sussex where she is director of Sussex Health Outcomes research & education in cancer. Her research interests include assessment of patient reported outcomes (PROs), supportive interventions for symptoms and side-effects of cancer and its treatments. In her career path she has published over 400 papers, book chapters and 3 textbooks. She also lectures and runs training workshops around the world in psychosocial oncology, quality of life assessment and communication skills.
In 2010, she was awarded the Pfizer/BOA Excellence in Oncology Lifetime Achievement Award and in 2016 she was made a Dame Commander of the order of the British Empire after her debut as fellow of the UK Academy of medical Sciences.
Profile LinkedInDean of Multidisciplinary Oncology Institute, Genolier Cancer Centre Switzerland
Dr. Matti Aapro is presently Dean of the Multidisciplinary Oncology Institut at Genolier. He is also a Board Member of ECCO (European CanCer Organisation) and he serves the International Society for Geriatric Oncology (SIOG) as Executive Board Member. He is past-President of the Multinational Association for Supportive Care in Cancer (MASCC). He is a member of the ESMO Faculty and chairs the ESMO 2017 Supportive/Palliative Care track. Dr. Aapro is Editor of Critical Reviews in Oncology/Hematology and the Journal of Geriatric Oncology. He has authored more than 350 publications and his major interests are new drug development, breast cancer, cancer in the elderly, and supportive care.
Profile LinkedInAssociate Professor Medical Oncology, University of Brescia, ASST-Spedali Civili, Brescia, Italy
Dr. Paolo Bossi is a medical oncologist devoted to head and neck cancer treatment. He is particularly dedicated to rare head and neck cancers (paranasal sinus cancer, adnexal cancer, nasopharyngeal cancer, salivary gland cancer). He is currently evaluating the impact of treatment and treatment-induced toxicities in elderly patients. He is greatly committed to supportive care and is studying the impact of the microbioma in the development of treatment-related toxicities. He is also dedicated to non-melanoma skin cancer, with a strong commitment to translational evaluation of the response to new drugs.
